{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"condition":["","colorectal cancer"],"disease":["","Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/37789"],"location":["China"],"study_start_month":["3"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Yiqi Chupi Powder for treating chemotherapy-related fatigue after colorectal cancer surgery: a multicenter randomized controlled trial","description":"Interventions: Experimental group:Oxaliplatin+Capecitabine+Yiqi Chupi Powder;Control group:Oxaliplatin+Capecitabine\nPrimary outcome(s): Piper fatigue score\nStudy Design: Cross-sectional","dates":{"creation":"2022-03-15"},"accession":"37789","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2200057546"],"Chinese Medicine Clinical Trials Registry":["ChiMCTR2200005712"],"International Traditional Medicine Clinical Trial Registry":["ITMCTR2200005712"]}}